CAS 1188266-14-9: 3,5-Di(methyl-d<sub>3</sub>) 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate
Formula:C17H12D6N2O6
InChI:InChI=1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3/i3D3,4D3
InChI key:InChIKey=HYIMSNHJOBLJNT-LIJFRPJRSA-N
SMILES:C(OC([2H])([2H])[2H])(=O)C=1C(C(C(OC([2H])([2H])[2H])=O)=C(C)NC1C)C2=C(N(=O)=O)C=CC=C2
Synonyms:- 3,5-Di(methyl-d3) 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate
- Nifedipine-d6
- 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, 3,5-di(methyl-d3) ester
Sort by
Found 3 products.
Nifedipine-d6
CAS:Nifedipine D6 is deuterium labeled nifedipine which is a potent blocker of calcium channel.Formula:C17H18N2O6Purity:98%Color and Shape:SolidMolecular weight:352.37Nifedipine-d6
CAS:Nifedipine-d6 is a radiolabeled form of nifedipine, which is a calcium channel blocker. Nifedipine-d6 binds to the L-type calcium channels and blocks the influx of Ca2+ ions into cardiomyocytes. This prevents an overload of Ca2+ ions and reduces the risk of arrhythmias and cardiac contractile dysfunction. Nifedipine-d6 has been shown to improve outcomes in rat cardiomyocyte cultures subjected to ischemia/reperfusion injury. It also has a pharmacokinetic profile similar to that of metformin hydrochloride, with an elimination half-life of 3 hours after administration.Formula:C17H12D6N2O6Purity:Min. 95%Molecular weight:352.37 g/molNifedipine-d6
CAS:Controlled ProductApplications Used as an antihypertensive and antianginal. A labelled dihydorpyridine calcium channel blocker. References Ali, S.L., et al.: Anal. Profiles Drug Subs., 18, 221 (1989), Soons, P.A., et al.: J. Pharm. Biomed. Anal., 9, 475 (1991), Brown, M.J., et al.: Lancet, 356, 366 (2000),Formula:C172H6H12N2O6Color and Shape:YellowMolecular weight:352.37
